| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |